Insider Transactions in Q2 2023 at Biocryst Pharmaceuticals Inc (BCRX)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 15
2023
|
Machelle Sanders Director |
SELL
Open market or private sale
|
Direct |
4,000
-13.51%
|
$28,000
$7.98 P/Share
|
|
Jun 14
2023
|
Nancy J Hutson Director |
SELL
Open market or private sale
|
Direct |
12,866
-13.59%
|
$102,928
$8.04 P/Share
|
|
Jun 13
2023
|
Jon P Stonehouse President & CEO |
SELL
Bona fide gift
|
Direct |
25,000
-2.4%
|
-
|
|
Jun 13
2023
|
Steven K Galson Director |
BUY
Grant, award, or other acquisition
|
Direct |
16,745
+36.12%
|
-
|
|
Jun 13
2023
|
Kenneth B Lee Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
16,745
+19.56%
|
-
|
|
Jun 13
2023
|
Alan G Levin Director |
BUY
Grant, award, or other acquisition
|
Direct |
16,745
+31.1%
|
-
|
|
Jun 13
2023
|
Vincent Milano Director |
BUY
Grant, award, or other acquisition
|
Direct |
16,745
+25.37%
|
-
|
|
Jun 13
2023
|
Machelle Sanders Director |
BUY
Grant, award, or other acquisition
|
Direct |
16,745
+36.12%
|
-
|
|
Jun 13
2023
|
Steve Aselage Director |
BUY
Grant, award, or other acquisition
|
Direct |
16,745
+20.91%
|
-
|
|
Jun 13
2023
|
Theresa Heggie Director |
BUY
Grant, award, or other acquisition
|
Direct |
16,745
+25.43%
|
-
|
|
Jun 13
2023
|
Amy E Mc Kee Director |
BUY
Grant, award, or other acquisition
|
Direct |
16,745
+36.12%
|
-
|
|
Jun 13
2023
|
Nancy J Hutson Director |
BUY
Grant, award, or other acquisition
|
Direct |
16,745
+15.03%
|
-
|
|
Jun 13
2023
|
George B Abercrombie Director |
BUY
Grant, award, or other acquisition
|
Direct |
16,745
+36.12%
|
-
|
|
May 31
2023
|
Alan G Levin Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,360
+6.27%
|
$10,880
$8.27 P/Share
|
|
May 31
2023
|
Vincent Milano Director |
BUY
Grant, award, or other acquisition
|
Direct |
680
+2.05%
|
$5,440
$8.27 P/Share
|
|
May 31
2023
|
Theresa Heggie Director |
BUY
Grant, award, or other acquisition
|
Direct |
680
+2.06%
|
$5,440
$8.27 P/Share
|
|
Apr 03
2023
|
Helen M. Thackray Chief R&D Officer |
SELL
Open market or private sale
|
Direct |
7,000
-3.27%
|
$56,000
$8.29 P/Share
|